Wei-Yih Chiu
Overview
Explore the profile of Wei-Yih Chiu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
267
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin Y, Hu H, Chung A, Lu J, Wu W, Chiu I, et al.
Head Neck
. 2025 Feb;
PMID: 39936351
Background: Distant metastasis is a leading cause of thyroid cancer (TC)-related deaths. Genetic profiling is typically limited to one sample per patient due to cost and sampling-risk concerns. Differences between...
2.
Wei L, Cheng Y, Chiu W, Kok S, Chang H, Cheng S, et al.
Head Neck
. 2024 Nov;
47(4):1151-1161.
PMID: 39611589
Aim: Antiresorptive therapy (ART) is commonly used in osteoporotic patients to prevent bone loss. This retrospective cohort study aimed to identify the risk factors associated with medication-related osteonecrosis of the...
3.
Lee J, Hsieh T, Kao Y, Tsai C, Huang H, Shih C, et al.
Mod Pathol
. 2023 Sep;
36(12):100336.
PMID: 37742927
Phosphaturic mesenchymal tumors (PMT) are uncommon neoplasms that cause hypophosphatemia/osteomalacia mainly by secreting fibroblast growth factor 23. We previously identified FN1::FGFR1/FGF1 fusions in nearly half of the PMTs and frequent...
4.
Wei L, Kok S, Lee Y, Chiu W, Wang J, Cheng S, et al.
J Formos Med Assoc
. 2020 Dec;
120(8):1572-1580.
PMID: 33309430
Background/purpose: Anti-resorptive agents are commonly used in cancer patients with bone metastasis or multiple myeloma (MM). An adverse event termed medication-related osteonecrosis of the jaws (MRONJ) was discovered in patients...
5.
Wei L, Kok S, Lee Y, Chiu W, Wang J, Cheng S, et al.
Oral Dis
. 2020 Nov;
28(1):182-192.
PMID: 33254278
Objectives: The aim of this study was to find out the prognosis of medication-related osteonecrosis of the jaws (MRONJ) in prostate cancer patients who received two different types of antiresorptive...
6.
Wu W, Su D, Chiu W, Lin C, Chen S, Wang S, et al.
J Formos Med Assoc
. 2020 Jul;
120(1 Pt 3):588-593.
PMID: 32682703
Background: The literature emphasizes the importance of matching the demand and supply of endocrinology and metabolism (EM) specialists. This study analyzed the current status of EM specialists in Taiwan. The...
7.
Tseng F, Lin L, Ko B, Chu T, Tsai S, Sheng W, et al.
J Formos Med Assoc
. 2019 Aug;
119(1 Pt 3):538-543.
PMID: 31427121
Background/purpose: This study analyzed the effects of the General Medicine Faculty Training Program (GMFTP), which was implemented in 2009. The training program includes a 7-hour basic training (BT) to introduce...
8.
Chao C, Yang R, Hung L, Tsai K, Peng J, Chang C, et al.
Arch Osteoporos
. 2018 Nov;
13(1):126.
PMID: 30446836
Introduction: Assessing PREM can assist physicians in improving patients' experiences. Patients with CKD are at an increased risk of exhibiting poor PREM and developing fractures. We aimed to assess whether...
9.
Chang L, Chang C, Chen P, Wang S, Chen Y, Tsai Y, et al.
Expert Opin Drug Saf
. 2018 Aug;
17(8):775-784.
PMID: 30067105
Background: Antithyroid drugs (ATDs) are known to cause various adverse drug reactions (ADRs) that can lead to treatment complexity and unpredictable risks. With the aim of ensuring safer drug use,...
10.
Chiu W, Yang W, Chien J, Lee J, Tsai K
PLoS One
. 2018 Apr;
13(4):e0196419.
PMID: 29694412
Background: Although bisphosphonate-related osteonecrosis of the jaw (ONJ) develops mainly after tooth extractions (TEs), the strength of the association between them and how the existence of the disease among bisphosphonate...